Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPDSeptember 14, 2007The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has released new standards for the diagnosis, management and prevention of chronic obstructive pulmonary disease (COPD). The latest recommendations emphasize the importance of proper diagnosis, assessment of the disease's severity, and the need for a better understanding of co-morbidities to improve treatment of disease. The GOLD report is updated annually online, but this is the first "complete makeover" since its initial publication in 2002. "This is an absolutely up-to-date summary of all the available evidence on the diagnosis, management and prevention of COPD," said Klaus Rabe, M.D., Ph.D., lead author of the report. The executive summary of the updated GOLD report appears in the second issue for September of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
According to the report, COPD is the fourth leading cause of death in the U.S. and is projected to be fifth worldwide by 2020. It currently affects 15 to 25 percent of adults over the age of 40, says Dr. Rabe, of the Department of Pulmonology at the Leiden University Medical Center in the Netherlands. Yet in spite of the prevalence and seriousness of COPD as a public health threat, COPD is relatively unknown and ignored by the public as well as by health officials. The new standards reflect the evolution of current scientific and medical thought. "One of the most important points is that we now say COPD is preventable and treatable," said Dr. Rabe. "There are steps we can take to prevent it, and it is no longer viewed with therapeutic nihilism." Other updates include: * New staging guidelines for determining the severity of COPD; * Management recommendations for exacerbations including the use of antibiotics; and * Recommendations for identifying and building the comprehensive healthcare teams that are necessary for the coordinated treatment of patients with COPD, who frequently present with co-morbidities. Unfortunately, despite the significant progress that has been made in the understanding and management of the disease, the behavioral and cultural factors that have pushed the disease into the top-five list of killer diseases worldwide remain largely unchanged. Cigarette smoking and secondhand smoke exposure are the most commonly encountered risk factors for COPD in the developed world. In developing countries, COPD arises primarily from long-term exposure to smoke from biomass fuel used for indoor cooking and heating. Women, who began smoking in higher numbers after World War II, and who bear the brunt of indoor exposures in developing countries, are now more likely to die of the disease than men. Furthermore, because COPD generally develops over a period of decades, the current rise in cases is unlikely to abate soon. "The prevalence and burden of COPD are projected to increase in the coming decades due to continued exposure to COPD risk factors and the changing age structure of the world's population," wrote the researchers. While the new guidelines represent a significant step toward more comprehensive treatment and understanding of COPD, they are also a work in progress. "Continuous updates of the literature provide the opportunity to identify areas of weakness," noted Leonardo M. Fabbri, M.D., who wrote an editorial on the report in the same issue of the journal. As examples, he cited areas of COPD research that require more investigation and further refinement, including the need to improve methods for determining the severity of the disease, and developing a more comprehensive approach to assessing co-morbidities. American Thoracic Society | |||||||||||||||||||||
|
Related COPD Current Events and COPD News Articles Long-term antibiotics reduce COPD exacerbations, raise questions Long-term use of a macrolide antibiotic may reduce the frequency of exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD) by as much as 35 percent, according to a London-based study. Cold virus found to manipulate genes Sneezing, runny nose and chills? You might blame the human rhinovirus (HRV), which causes 30 to 50 percent of common colds. But in reality, it's not the virus itself but HRV's ability to manipulate your genes that is the true cause of some of the most annoying cold symptoms. Depression may increase exacerbations, hospitalizations in COPD It is well known that patients with chronic obstructive pulmonary disease (COPD) frequently suffer from depression and anxiety, but according to new research, depression and anxiety may actually cause increased hospitalizations and exacerbations. First comprehensive genomic study of common cold reveals new treatment targets Today, scientists from Procter & Gamble (P&G), the University of Calgary and the University of Virginia announced results from the first study to examine the entire human genome's response to the most common cold virus, human rhinovirus. UCSF Fresno leading-edge study lends hope to emphysema patients Patients in the Valley with emphysema might soon be breathing a little easier thanks to a new airway bypass study called the Exhale Airways Stents for Emphysema (EASE) trial. Beta-blockers reduce mortality in patients with COPD after vascular surgery In the first study to directly examine the effects of beta-blockers on surgical patients with chronic obstructive pulmonary disease (COPD), researchers have found that, contrary to previous thought, beta-blockers significantly reduce mortality in COPD patients. Common bronchodilator linked to increased deaths A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease (COPD) has been linked to a one-third higher risk of cardiovascular-related deaths. COPD? Eat your veggies You know it's good for you in other ways, but could eating your broccoli also help patients with chronic lung disease? It just might. Key component of debilitating lung disease identified For the first time, researchers have demonstrated a close correlation between the decline in a key component of the lung's antioxidant defense system and the progression of chronic obstructive pulmonary disease (COPD) in humans. Creating lung cancer risk models for specific populations refines prediction Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of Cancer Prevention Research. More COPD Current Events and COPD News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||